Glycosaminoglycan Degradation-Inhibitory Lactic Acid Bacteria Ameliorate 2,4,6-Trinitrobenzenesulfonic Acid-Induced Colitis in Mice |
Lee, Bo-Mi
(Department of Life and Nanopharmaceutical Sciences and Department of Pharmaceutical Science, Kyung Hee University)
Lee, Jung-Hee (Department of Life and Nanopharmaceutical Sciences and Department of Pharmaceutical Science, Kyung Hee University) Lee, Hye-Sung (Department of Life and Nanopharmaceutical Sciences and Department of Pharmaceutical Science, Kyung Hee University) Bae, Eun-Ah (Department of Life and Nanopharmaceutical Sciences and Department of Pharmaceutical Science, Kyung Hee University) Huh, Chul-Sung (R & D Center, Korea Yakult Co., Ltd.) Ahn, Young-Tae (R & D Center, Korea Yakult Co., Ltd.) Kim, Dong-Hyun (Department of Life and Nanopharmaceutical Sciences and Department of Pharmaceutical Science, Kyung Hee University) |
1 | Bowen, J. M., A. M. Stringer, R. J. Gibson, A. S. Yeoh, S. Hannam, and D. M. Keefe. 2007. VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss. Cancer Biol. Ther. 6: 1449-1454 DOI PUBMED ScienceOn |
2 | Campieri, M. and P. Gionchetti. 1999. Probiotics in inflammatory bowel disease: New insight to pathogenesis or a possible therapeutic alternative. Gastroenterology 116: 1246-1260 DOI ScienceOn |
3 | Chung, K. T., G. E. Fulk, and M. W. Slein. 1975. Tryptophanase of fecal flora as a possible factor in the etiology of colon cancer. J. Natl. Cancer Inst. 54: 1073-1078 DOI PUBMED |
4 | Fukuta, M., A. Chen, A. Klepper, S. Krishnareddy, A. S. Vamadevan, L. S. Thomas, et al. 2006. Cox-2 is regulated by toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. Gastroenterology 131: 862-877 DOI ScienceOn |
5 | Ganguly, N. K., J. G. Kingham, B. Lloyd, R. S. Lloyd, C. P. Price, D. R. Triger, and R. Wright. 1978. Acid hydrolases in monocytes from patients with inflammatory bowel disease, chronic liver disease, and rheumatoid arthritis. Lancet 1: 1073-1075 PUBMED |
6 | Gesner, B. M. and C. R. Jenkin. 1961. Production of heparinase by bacteroides. J. Bacteriol. 81: 595-604 |
7 | Sartor, R. B. 1994. Cytokines in intestinal inflammation:Pathophysiological and clinical consideration. Gastroenterology 106: 533-539 DOI PUBMED ScienceOn |
8 | Singer, I. I., D. W. Kawka, S. Schloemann, T. Tessner, T. Riehl, and W. F. Stenson. 1998. Cyclooxygenase-2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 115: 297-306 DOI ScienceOn |
9 | Berrebi, D., J. Languepin, L. Ferkdadji, A. Foussat, P. De Lagausie, R. Paris, et al. 2003. Cytokines, chemokine receptors, and homing molecule distribution in the rectum and stomach of pediatric patients with ulcerative colitis. J. Pediatr. Gastroenterol. Nutr. 37: 300-308 DOI ScienceOn |
10 | Grabig, A., D. Paclik, C. Guzy, A. Dankof, D. C. Baumgart, J. Erckenbrecht, et al. 2006. Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and tolllike receptor 4-dependent pathways. Infect. Immun. 74: 4075-4082 DOI ScienceOn |
11 | Ingalls, R. R., H. Heine, E. Lien, A. Yoshimura, and D. Golenbock. 1999. Lipolysaccharide recognition, CD14, and lipolysaccharide receptors. Infect. Dis. Clin. N. Am. 13: 341-353 DOI ScienceOn |
12 | Shin, Y. W., E. A. Bae, S. S. Kim, Y. C. Lee, and D .H. Kim. 2005. Effect of ginsenoside Rb1 and compound K in chronic oxazolone-induced mouse dermatitis. Int. Immunopharmacol. 5:1183-1191 DOI ScienceOn |
13 | Simon, G. L. and S. L. Gorbach. 1984. Intestinal flora in health and disease. Gastroenterology 86: 174-193 PUBMED ScienceOn |
14 | Onderdonk, A. B., J. A. Aermos, and J. G. Barblett. 1979. The role of the intestinal microflora in experimental colitis. Am. J. Clin. Nutr. 30: 1819-1825 ScienceOn |
15 | Belmiro, C. L., H. S. Souza, C. C. Elia, M. T. Castelo-Branco, F. R. Silva, R. L. Machado, and M. S. Pavao. 2005. Biochemical and immunohistochemical analysis of glycosaminoglycans in inflamed and non-inflamed intestinal mucosa of patients with Crohn's disease. Int. J .Colorectal Dis. 20: 295-304 DOI ScienceOn |
16 | Benno, P., C. E. Leijonmarck, U. Monsen, and A. Uribe. 1993. Functional alteration of the microflora in patients with ulcerative colitis. Scand. J. Gastroenterol. 28: 839-844 DOI ScienceOn |
17 | Kruis, W. 2004. Antibiotics and probiotics in inflammatory bowel disease. Aliment. Pharmacol. Ther. 20(Suppl. 4): 75-78 DOI |
18 | Rhodes, J. M., R. Gallimore, and E. Elias. 1985. Fecal mucus degrading glycosidase in ulcerative colitis and Crohn's disease. Gut 26: 761-765 DOI ScienceOn |
19 | Han. W., A. Mercenier, A. Ait-Belgnaoui, S. Pavan, F. Lamine, I. I. van Swam, et al. 2006. Improvement of an experimental colitis in rats by lactic acid bacteria producing superoxide dismutase. Inflamm. Bowel Dis. 12: 1044-1052 DOI ScienceOn |
20 | Chung, Y. W., J. H. Choi, T. Y. Oh, C. S. Eun, and D. S. Han. 2008. Lactobacillus casei prevents the development of dextran sulphate sodium-induced colitis in toll-like receptor 4 mutant mice. Clin. Exp. Immunol. 151: 182-189 DOI ScienceOn |
21 | Sartor, R. B. 2004. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: Antibiotics, probiotics and prebiotics. Gastroenterology 126: 1620-1633 DOI PUBMED ScienceOn |
22 | Chandran, P., S. Satthapom, A. Robins, and O. Eremin. 2003. Inflammatory bowel disease: Dysfunction of GALT and gut bacterial flora (II). Surgeon 1:125-136 DOI ScienceOn |
23 | Lee, H. S., S. Y. Han, E. A. Bae, C. S. Huh, Y. T. Ahn, J. H. Kee, and D. H. Kim. 2008. Lactic acid bacteria inhibit proinflammatory cytokine expression and bacterial glycosaminoglycan degradation activity in dextran sulfate sodiuminduced colitic mice. Int. Immunopharmacol. 8: 574-580 DOI ScienceOn |
24 | Hill, M. J. and D. S. Drasar. 1975. The normal colonic bacterial flora. Gut 16: 318-323 DOI ScienceOn |
25 | Perdigon, G.., W. E. B. de Jorrat, S. F. de Petrino, and M. Valerde de Budeguer. 1991. Effect of oral administration of Lactobacillus casei on various biological functions of the host. Food Agric. Immunol. 3: 93-102 DOI |
26 | Cario, E. and D. K. Podolsky. 2000. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect. Immun. 68:7010-7017 DOI ScienceOn |
27 | Mullane, K. M., R. Kraemer, and B. Smith. 1985. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J. Pharmacol. Methods 14: 157-167 DOI ScienceOn |
28 | Peran, L., S. Sierra, M. Comalada, F. Lara-Villoslada, E. Bailon, A. Nieto, et al. 2007. A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis. Br. J. Nutr. 97:96-103 DOI ScienceOn |
29 | Keighley, M. R. and Y. Arabi. 1978. Influence of inflammatory bowel disease in intestinal microflora. Gut 19:1099-1104 DOI ScienceOn |
30 | Barthet, M., L. Dubucquoy, S. Garcia, S. Gasmi, P. Descreumaux, J. F. Colombel, J. C. Grimaud, J. Iovanna, and J. C. Dagorn. 2003. Pancreatic changes in TNBS-induced colitis in mice. Gastroenterol. Clin. Biol. 27: 895-900 PUBMED ScienceOn |
31 | Salyers, A. A., J. R. Vercellotti, S. E. H. West, and T. D. Wilkins. 1977. Fermentation of mucin and plant polysaccharides by strains of Bacteroides from the human colon. Appl. Environ. Microbiol. 34: 319-322 |
32 | Han, S. Y., C. S. Huh, Y. T. Ahn, K. S. Lim, Y. J. Baek, and D. H. Kim. 2005. Hepatoprotective effect of lactic acid bacteria. J. Microbiol. Biotechnol. 15: 887-890 과학기술학회마을 ScienceOn |
33 | Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254 DOI PUBMED ScienceOn |
34 | Bai, A., N. Lu, Y. Guo, and X. Fan. 2008. Tanshinone IIA ameliorates trinitrobenzene sulfonic acid (TNBS)-induced murine colitis. Dig. Dis. Sci. 53: 421-428 DOI ScienceOn |
35 | Stiles, M. E. and W. H. Holzapfel. 1997. Lactic acid bacteria of foods and their current taxonomy. Int. J. Food Microbiol. 36: 1-29 DOI ScienceOn |
36 | Collins, M. P. and G. R. Gibson. 1999. Probiotics, prebiotics, and synbiotics: Approaches for modulating the microbial ecology of the gut. Am. J. Clin. Nutr. 69: s1052-s1057 DOI |
37 | Duchmann, R., I. Kaiser, E. Hermann, W. Mayet, K. Ewk, and K. H. Meyer zum Buschenfelde. 1995. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease. Clin. Exp. Immunol. 102: 448-455 DOI |
38 | Gilliland, S. E. 1990. Health and nutritional benefits from lactic acid bacteria. FEMS Microbiol. Rev. 7: 175-188 PUBMED ScienceOn |
39 | Binder, V. 2004. Epidemiology of IBD during the twentieth century: An integrated view. Best Pract. Res. Clin. Gastroenterol. 18: 463-479 DOI PUBMED ScienceOn |